Back |
home / stock / vyne / vyne message board
Subject | By | Source | When |
---|---|---|---|
Just now noticed that $VYNE gained 21% over | jugs | investorshub | 09/19/2020 4:07:29 PM |
We closed on Friday a week ago at | jugs | investorshub | 09/18/2020 6:04:43 PM |
Beautiful | artfulife | investorshub | 09/16/2020 10:02:36 PM |
I'm grateful that I get to work with them. | SpockJones | investorshub | 09/16/2020 8:17:03 PM |
Now down $8K for me. | jugs | investorshub | 09/16/2020 3:24:14 PM |
Down 3 g's | pickspicks1 | investorshub | 09/16/2020 3:16:48 PM |
For a moment this morning I was actually | jugs | investorshub | 09/16/2020 3:11:45 PM |
Rolling along slow and steady | pickspicks1 | investorshub | 09/16/2020 2:37:58 PM |
Those aren't question marks at the end of | artfulife | investorshub | 09/15/2020 11:07:08 PM |
Amazing. Im sure you and your coworkers make | artfulife | investorshub | 09/15/2020 9:50:52 PM |
Thank you for going the extra mile. Much | jugs | investorshub | 09/15/2020 8:24:24 PM |
sorry - maybe this will flow thru properly | Billr05 | investorshub | 09/15/2020 8:16:44 PM |
No numerical target points? | jugs | investorshub | 09/15/2020 7:42:09 PM |
not the best cut and paste from my | Billr05 | investorshub | 09/15/2020 6:40:20 PM |
News, Short Squeeze, Breakout and More Instantly...
VYNE Therapeutics Inc Com Company Name:
VYNE Stock Symbol:
NASDAQ Market:
VYNE Therapeutics Inc Com Website:
BRIDGEWATER, N.J., July 16, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory con...
BRIDGEWATER, N.J., July 09, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory con...
BRIDGEWATER, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory co...